Upgrade to SI Premium - Free Trial

AxoGen, Inc. (AXGN) PT Lowered to $53 at Truist Securities

October 1, 2026 5:23 AM
Truist Securities analyst Ravi Misra lowered the price target on AxoGen, Inc. (NASDAQ: AXGN) to $53.00 (from $60.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change